nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—Tetany—Riluzole—amyotrophic lateral sclerosis	0.0646	0.127	CcSEcCtD
Gentamicin—LRP2—Retinoid metabolism and transport—PLB1—amyotrophic lateral sclerosis	0.057	0.176	CbGpPWpGaD
Gentamicin—Thrombocytopenic purpura—Riluzole—amyotrophic lateral sclerosis	0.0449	0.0883	CcSEcCtD
Gentamicin—LRP2—medulla oblongata—amyotrophic lateral sclerosis	0.0345	0.206	CbGeAlD
Gentamicin—LRP2—spinal cord—amyotrophic lateral sclerosis	0.0308	0.183	CbGeAlD
Gentamicin—LRP2—Diseases associated with visual transduction—PLB1—amyotrophic lateral sclerosis	0.0291	0.0899	CbGpPWpGaD
Gentamicin—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.028	0.055	CcSEcCtD
Gentamicin—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.028	0.055	CcSEcCtD
Gentamicin—LRP2—nervous system—amyotrophic lateral sclerosis	0.0259	0.154	CbGeAlD
Gentamicin—LRP2—central nervous system—amyotrophic lateral sclerosis	0.025	0.149	CbGeAlD
Gentamicin—LRP2—cerebellum—amyotrophic lateral sclerosis	0.0244	0.145	CbGeAlD
Gentamicin—LRP2—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.02	0.0617	CbGpPWpGaD
Gentamicin—LRP2—brain—amyotrophic lateral sclerosis	0.0198	0.118	CbGeAlD
Gentamicin—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.0177	0.0349	CcSEcCtD
Gentamicin—LRP2—Retinoid metabolism and transport—APOE—amyotrophic lateral sclerosis	0.0175	0.0542	CbGpPWpGaD
Gentamicin—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.0171	0.0336	CcSEcCtD
Gentamicin—Deafness—Riluzole—amyotrophic lateral sclerosis	0.0171	0.0336	CcSEcCtD
Gentamicin—Purpura—Riluzole—amyotrophic lateral sclerosis	0.0159	0.0312	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.0158	0.0311	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.0147	0.0455	CbGpPWpGaD
Gentamicin—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.0139	0.0274	CcSEcCtD
Gentamicin—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0265	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.0127	0.0392	CbGpPWpGaD
Gentamicin—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.012	0.0235	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.0116	0.0358	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0227	CcSEcCtD
Gentamicin—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0226	CcSEcCtD
Gentamicin—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.011	0.0216	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.0108	0.0333	CbGpPWpGaD
Gentamicin—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0207	CcSEcCtD
Gentamicin—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0207	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.0101	0.0313	CbGpPWpGaD
Gentamicin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00934	0.0184	CcSEcCtD
Gentamicin—LRP2—Diseases associated with visual transduction—APOE—amyotrophic lateral sclerosis	0.00896	0.0277	CbGpPWpGaD
Gentamicin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00851	0.0167	CcSEcCtD
Gentamicin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00827	0.0163	CcSEcCtD
Gentamicin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00824	0.0162	CcSEcCtD
Gentamicin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00798	0.0157	CcSEcCtD
Gentamicin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00795	0.0156	CcSEcCtD
Gentamicin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00784	0.0154	CcSEcCtD
Gentamicin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00757	0.0149	CcSEcCtD
Gentamicin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00751	0.0148	CcSEcCtD
Gentamicin—SLC22A6—brain—amyotrophic lateral sclerosis	0.00748	0.0446	CbGeAlD
Gentamicin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00736	0.0145	CcSEcCtD
Gentamicin—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00702	0.0138	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00695	0.0215	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00684	0.0135	CcSEcCtD
Gentamicin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00675	0.0133	CcSEcCtD
Gentamicin—LRP2—Disease—TPK1—amyotrophic lateral sclerosis	0.00674	0.0208	CbGpPWpGaD
Gentamicin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00653	0.0128	CcSEcCtD
Gentamicin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00619	0.0122	CcSEcCtD
Gentamicin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00597	0.0117	CcSEcCtD
Gentamicin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00594	0.0117	CcSEcCtD
Gentamicin—LRP2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00565	0.0174	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00565	0.0174	CbGpPWpGaD
Gentamicin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00553	0.0109	CcSEcCtD
Gentamicin—LRP2—Disease—VTA1—amyotrophic lateral sclerosis	0.00539	0.0167	CbGpPWpGaD
Gentamicin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00531	0.0105	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00526	0.0163	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00516	0.016	CbGpPWpGaD
Gentamicin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00497	0.00977	CcSEcCtD
Gentamicin—LRP2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.0048	0.0148	CbGpPWpGaD
Gentamicin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00478	0.00939	CcSEcCtD
Gentamicin—Rash—Riluzole—amyotrophic lateral sclerosis	0.00474	0.00932	CcSEcCtD
Gentamicin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00473	0.00931	CcSEcCtD
Gentamicin—Headache—Riluzole—amyotrophic lateral sclerosis	0.00471	0.00926	CcSEcCtD
Gentamicin—LRP2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00451	0.0139	CbGpPWpGaD
Gentamicin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00446	0.00878	CcSEcCtD
Gentamicin—LRP2—Disease—CHMP2B—amyotrophic lateral sclerosis	0.00408	0.0126	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—DAO—amyotrophic lateral sclerosis	0.00408	0.0126	CbGpPWpGaD
Gentamicin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00406	0.0125	CbGpPWpGaD
Gentamicin—LRP2—Disease—PLB1—amyotrophic lateral sclerosis	0.00369	0.0114	CbGpPWpGaD
Gentamicin—LRP2—Disease—VCP—amyotrophic lateral sclerosis	0.00329	0.0102	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00309	0.00956	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSR—amyotrophic lateral sclerosis	0.00286	0.00882	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.0026	0.00803	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.00259	0.00799	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00243	0.00752	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00243	0.00751	CbGpPWpGaD
Gentamicin—LRP2—Disease—CST3—amyotrophic lateral sclerosis	0.00236	0.0073	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00234	0.00724	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00231	0.00712	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00223	0.0069	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.00214	0.00661	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00207	0.00639	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00198	0.00613	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00196	0.00606	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00192	0.00593	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00184	0.0057	CbGpPWpGaD
Gentamicin—LRP2—Disease—CASP9—amyotrophic lateral sclerosis	0.00172	0.00531	CbGpPWpGaD
Gentamicin—LRP2—Disease—ERBB4—amyotrophic lateral sclerosis	0.00147	0.00454	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.00147	0.00453	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.00135	0.00416	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00126	0.0039	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00126	0.00389	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00124	0.00382	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.0012	0.00372	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00116	0.00358	CbGpPWpGaD
Gentamicin—LRP2—Disease—APOE—amyotrophic lateral sclerosis	0.00114	0.00351	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00105	0.00325	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00105	0.00325	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.00103	0.00318	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000968	0.00299	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000953	0.00294	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000937	0.00289	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000856	0.00264	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000797	0.00246	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTGS2—amyotrophic lateral sclerosis	0.00078	0.00241	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000658	0.00203	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000653	0.00202	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000507	0.00157	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000479	0.00148	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.00043	0.00133	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.000325	0.001	CbGpPWpGaD
